|
|
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Vincent Ribrag
,
Serge Koscielny
,
Jacques Bosq
,
Thibaut Leguay
,
Olivier Casasnovas
et al.
Journal articles
inserm-01419476v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study.
Mira Tout
,
Olivier Casasnovas
,
Michel Meignan
,
Thierry Lamy
,
Franck Morschhauser
et al.
Journal articles
hal-01547802v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
Loic Ysebaert
,
Roch Houot
,
Ibrahim Yakoub-Agha
,
Franck Morschhauser
,
Charles Herbaux
et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles
hal-01290424v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study
Guillaume Cartron
,
Sophie de Guibert
,
Marie-Sarah Dilhuydy
,
Franck Morschhauser
,
Veronique Leblond
et al.
Journal articles
hal-01147035v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Sophie Langner-Lemercier
,
Caroline Houillier
,
Carole Soussain
,
Hervé Ghesquières
,
Olivier Chinot
et al.
Journal articles
hal-01290413v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
Bertrand Coiffier
,
Catherine Thieblemont
,
Sophie de Guibert
,
Jehan Dupuis
,
Vincent Ribrag
et al.
Journal articles
hal-01295660v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A dose-escalation study of SAR3419, an anti-CD19 antibody maytansinoid conjugate, administered by intravenous infusion once weekly in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Vincent Ribrag
,
Jehan Dupuis
,
Herve Tilly
,
Franck Morschhauser
,
Fabrice Laine
et al.
Journal articles
hal-01068681v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA
Roch Houot
,
Carole Soussain
,
Hervé Tilly
,
Corinne Haioun
,
Catherine Thieblemont
et al.
Journal articles
hal-01295653v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
Ciara L. Freeman
,
Franck Morschhauser
,
Laurie Sehn
,
Mark Dixon
,
Richard Houghton
et al.
Journal articles
hal-01275480v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Emilie Reboursiere
,
Fabien Le Bras
,
Charles Herbaux
,
Emmanuel Gyan
,
Aline Clavert
et al.
Journal articles
hal-01475957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program
Aurore Perrot
,
Hélène Monjanel
,
Reda Bouabdallah
,
Philippe Quittet
,
Clémentine Sarkozy
et al.
Journal articles
hal-01259439v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.
Emmanuel Bachy
,
Roch Houot
,
Franck Morschhauser
,
Anne Sonet
,
Pauline Brice
et al.
Journal articles
hal-00933219v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
Reinhard Marks
,
Lorenz Trümper
,
Tsvetan Biyukov
,
Meera Patturajan
,
Marie-Laure Casadebaig Bravo
et al.
Journal articles
hal-01274886v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|